Guanhao Biotech Co (SZSE:300238) Ending Cash Position : ¥88.1 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Ending Cash Position?

Guanhao Biotech Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥88.1 Mil.

Guanhao Biotech Co's quarterly Ending Cash Position declined from Sep. 2023 (¥131.2 Mil) to Dec. 2023 (¥96.1 Mil) and declined from Dec. 2023 (¥96.1 Mil) to Mar. 2024 (¥88.1 Mil).

Guanhao Biotech Co's annual Ending Cash Position declined from Dec. 2021 (¥159.3 Mil) to Dec. 2022 (¥120.3 Mil) and declined from Dec. 2022 (¥120.3 Mil) to Dec. 2023 (¥96.1 Mil).

Guanhao Biotech Co Ending Cash Position Historical Data

The historical data trend for Guanhao Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Ending Cash Position Chart

Guanhao Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

139.57

156.20

159.31

120.32

96.11

Guanhao Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															120.07	127.96	131.25	96.11	88.12

Guanhao Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Guanhao Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	120.315	+	-24.207
	=	96.1

Guanhao Biotech Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	96.109	+	-7.989
	=	88.1

Guanhao Biotech Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Guanhao Biotech Co (SZSE:300238) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530

Website

http://www.grandhopebio.com

Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.

Executives

Liu De Wang	Directors, executives
Zhao Jun Hui	Directors, executives
Yang Guo Sheng	Supervisors
Zhu Wei Ping	Director
Hu Jun	Securities Affairs Representative
Jia Bao Rong	Executives
Jia Jun Chao	Executives
Di Pu	Director
Zhuo Fu Min	Director
Guo Xiao Ming	Executives
Zhang Hong Tao	Executives
Zhao Wen Jie	Executives
Guan Xin	Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines